Europe Enteral Feeding Market Research Report Information by Device Type (feeding pump, enteral syringes, administration sets, consumables), by age group (Adult and Pediatric), by application (Oncology, Diabetes, Hypermetabolism, Neurological Disorder, Others) by End Users (Hospitals, Home Care, Ambulatory Surgery Centers) and by country (Germany, France, UK, Italy, Spain, Netherlands, Nordics, rest of Europe)- Forecast till 2032

Europe Enteral Feeding Market

Europe enteral feeding market size was valued at USD 1.18 Billion in 2023 And is projected to grow from USD 1.24 Billion in 2024 to USD 2.12 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.09 % during the forecast period (2024 - 2032).

The expected growth in the market can be attributed to the increasing incidence of preterm births, the growing prevalence of chronic diseases, and shift from parental nutrition to enteral nutrition. However, the market is also held back by insufficient reimbursement policies and complications associated with enteral feeding devices.

Europe Enteral Feeding Market Trends

• Increasing incidence of preterm births

For preterm newborns, enteral feeding is the recommended mode of nutrition delivery. Even yet, parenteral nourishment is still a viable option for post term delivery nutrition needs. Furthermore, enteral feeding continues to offer substantial non-nutritional and nutritional advantages. Furthermore, the European Commission reports that the number of premature births in Europe is increasing, with an estimated 500,000 births occurring each year. This is because women are having children later in life, suffering from obesity and diabetes at higher rates, and having more children as a result of reproductive treatments. These infants have an increased risk of both acute and chronic health problems, including learning impairments, respiratory infections, and mobility difficulties like cerebral palsy.

Furthermore, infants born with genetic disorders, such as congenital genetic disorders and rare diseases like Prader-Willi Syndrome, necessitate enteral feeding via tubes. As a result, rising demand for enteral feeding therapies in neonates and infants is propelling revenue growth in the European enteral feeding market.

Europe Enteral Feeding Market Segment Insights

Europe enteral feeding market device Insights

The Europe enteral feeding market, based on device, includes feeding pump, feeding tube, nasoenteric feeding tubes, enteral syringes, administration sets, and consumables. The feeding Pump segment held the largest market in 2022. The nasoenteric feeding tubes segment is expected to register the highest CAGR from 2024 to 2032.

Feeding tube can help people who have trouble eating get the nutrition they need. Doctors often use it at the end of life to help people stay more comfortable, though some patients choose to opt out of tube feeding

Figure 2: Europe Enteral Feeding Market, by Device Type, 2022 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe Enteral Feeding Age Group Insights

The Europe enteral feeding market segmentation, based on Age Group, includes adult, and pediatric. The pediatric segment held the largest market in 2022 and expected to reach highest CAGR from 2024 to 2032.

Increasing pediatric population suffering from malnutrition is a key factor fueling the market growth. Children with malnutrition require nutritional supplements through enteral feeding for the ones that have swallowing difficulties. Therefore, for these patients, enteral feeding is the first choice to provide adequate nutrients for the ones that are unable to take the nutrients. Thus, the rising incidence of several health conditions resulting in malnutrition and the growing geriatric population will amplify the industry revenue.

 Europe enteral feeding Application Insights

The Europe enteral feeding market segmentation, based on application, On the basis of application, the Europe enteral feeding market has been classified as oncology, diabetes, hypermetabolism, neurological disorder, and others. The diabetes segment held the largest market in 2022. The oncology segment is expected to register the highest CAGR 2024 to 2032.

Incidences of diabetes have increased over the years and are expected to increase further. As per 2021 update by the International Diabetes Federation (IDF), approximately 537 million adults (20-79 years) are living with diabetes. As per the same source, the total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Enteral nutrition plays an important role in reducing the risk of malnutrition in diabetic patients by providing the necessary macro-and micronutrients, such as energy, protein, vitamins, and minerals. Thus, the demand for enteral feeding devices is likely to increase among the diabetic patient population in the near future.

Europe Enteral Feeding End User Insights

The Europe enteral feeding market has been segmented, based on end user into hospital, home care, and ambulatory surgery centers. The hospital segment held the largest market in 2022. The ambulatory surgery centers segment is expected to register the highest CAGR from 2024 to 2032.

The utilization rate of enteral feeding devices in hospitals is high owing to the rising availability of these products in hospitals and placement of tubes in hospitals with high success rate. In addition, shift from parenteral nutrition to enteral nutrition are also supporting the growth of the hospitals segment. Additionally, hospitals have different departments allotted to dermatology, orthopedics, cardiology, neurology, etc. The enteral feeding device is now widely used in most departments. Thus, the use of enteral feeding devices is high in hospitals due to high demand from multiple departments.

Europe Enteral Feeding Country Insights

The Europe enteral feeding market has been segmented based on country into Germany, France, the UK, Italy, Spain, the Netherlands, the Nordics, and the Rest of Europe. The increasing incidence of preterm births, advancements in enteral feeding devices, and growing prevalence of chronic diseases are the key driving factors for the Europe enteral feeding market. According to the European Foundation for the Care of Newborn Infants, the prevalence rate of preterm birth is an average of 7.3% of all live births in Europe.  Moreover, technological advancements in enteral feeding devices also lead to increasing preferences for these devices.

Figure 3: EUROPE ENTERAL FEEDING MARKET BY COUNTRY 2023 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Additionally, according to National Library of Medicine, it is estimated that there were around 276,239 new cases of cancer in Spain. The patients may have difficulties drinking or eating by mouth during cancer treatment.

Chronic diseases, such as digestive diseases, are more common in the elderly population and the geriatric population is high in Europe.

Europe Enteral Feeding Market Key Market Players & Competitive Insights

The Europe enteral feeding market is distinguished by the presence of numerous Europe, regional, and local players catering to the enteral feeding techniques that are evolving at a rapid pace. Furthermore, the increasing incidence of preterm births is further driving the growth of Europe enteral feeding market during the forecast period. The major players have adopted a strategy of obtaining regulatory approval from government agencies for their products and signing contracts and agreements to broaden their reach and reduce operational costs. Mergers and collaborations were also observed to expand the company's product portfolio, as well as introduce new software and services.

Fresenius Kabi AG is a pharmaceutical company with a wide portfolio that includes intravenously administered drugs, infusion therapy, clinical nutrition, medical devices, and transfusion technology. Its product portfolio also comprises a comprehensive range of I.V. generic drugs, infusion therapies, clinical nutrition products, and the medical devices for administering these products.

Moreover in march 2022 Fresenius Kabi closed the majority stake acquisition of mAbxience Holding S.L. (“mAbxience”), a leading international biopharmaceutical company

Key Companies Europe enteral feeding market in market includes.

• BRAUN SE (Germany)


• Cardinal Health (Us)


• Fresenius Kabi AG (Germany)


• Danone S.A. (France)


• Medline Industries Inc (US)


• Boston Scientific Corporation (US


• BD (US)


• Cook (US)


• Vygon (France)


• Moog Inc. (US)

Europe enteral feeding market Industry Developments

• April 2022, Fresenius Kabi launched a new enteral nutrition product app that provides detailed product-related information as well as also includes a fast comparison tool to compare nutritional values against reference nutrient intakes

Europe enteral feeding Segmentation

 Europe enteral feeding Device Outlook

• Feeding pump


• enteral syringes


• administration sets


• consumables

Europe enteral feeding Age Group Outlook

• Adult


• Pediatric

Europe enteral feeding Application Outlook

• Oncology


• Diabetes


• Hypermetabolism


• Neurological Disorder


• Others

Europe enteral feeding End user Outlook

• Hospitals


• Home Care


• Ambulatory Surgery Centers

Europe enteral feeding Country Outlook

• Germany
  
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Netherlands
  
  
  • Nordics
  
  
  • Rest Of Europe